AR013251A1 - PROCEDIMIENTO PARA LA PRODUCCION DE MUTEíNAS DE POLIPÉPTIDOS EUCARIoTICOS, PROCEDIMIENTO PARA LA PRODUCCIoN DE UNA CÉLULA HUMANA, QUE NO DE LUGAR A UN INIDIVIDUO COMPLETO, QUE EXPRESA UNA MUTEíNA DE UN POLIPÉPTIDO BLANCO HUMANO, CÉLULA HUMANA OBTENIBLE MEDIANTE DICHO PROCESO Y USO DE DICHA CÉLULA HU - Google Patents

PROCEDIMIENTO PARA LA PRODUCCION DE MUTEíNAS DE POLIPÉPTIDOS EUCARIoTICOS, PROCEDIMIENTO PARA LA PRODUCCIoN DE UNA CÉLULA HUMANA, QUE NO DE LUGAR A UN INIDIVIDUO COMPLETO, QUE EXPRESA UNA MUTEíNA DE UN POLIPÉPTIDO BLANCO HUMANO, CÉLULA HUMANA OBTENIBLE MEDIANTE DICHO PROCESO Y USO DE DICHA CÉLULA HU

Info

Publication number
AR013251A1
AR013251A1 ARP980103617A ARP980103617A AR013251A1 AR 013251 A1 AR013251 A1 AR 013251A1 AR P980103617 A ARP980103617 A AR P980103617A AR P980103617 A ARP980103617 A AR P980103617A AR 013251 A1 AR013251 A1 AR 013251A1
Authority
AR
Argentina
Prior art keywords
procedure
production
muteins
inidividuo
eucharitic
Prior art date
Application number
ARP980103617A
Other languages
English (en)
Spanish (es)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR013251(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of AR013251A1 publication Critical patent/AR013251A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
ARP980103617A 1997-07-23 1998-07-23 PROCEDIMIENTO PARA LA PRODUCCION DE MUTEíNAS DE POLIPÉPTIDOS EUCARIoTICOS, PROCEDIMIENTO PARA LA PRODUCCIoN DE UNA CÉLULA HUMANA, QUE NO DE LUGAR A UN INIDIVIDUO COMPLETO, QUE EXPRESA UNA MUTEíNA DE UN POLIPÉPTIDO BLANCO HUMANO, CÉLULA HUMANA OBTENIBLE MEDIANTE DICHO PROCESO Y USO DE DICHA CÉLULA HU AR013251A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97112639 1997-07-23

Publications (1)

Publication Number Publication Date
AR013251A1 true AR013251A1 (es) 2000-12-13

Family

ID=8227102

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980103617A AR013251A1 (es) 1997-07-23 1998-07-23 PROCEDIMIENTO PARA LA PRODUCCION DE MUTEíNAS DE POLIPÉPTIDOS EUCARIoTICOS, PROCEDIMIENTO PARA LA PRODUCCIoN DE UNA CÉLULA HUMANA, QUE NO DE LUGAR A UN INIDIVIDUO COMPLETO, QUE EXPRESA UNA MUTEíNA DE UN POLIPÉPTIDO BLANCO HUMANO, CÉLULA HUMANA OBTENIBLE MEDIANTE DICHO PROCESO Y USO DE DICHA CÉLULA HU
ARP080103620A AR068104A2 (es) 1997-07-23 2008-08-20 Procedimiento in vitro para la produccion de muteinas de polipeptidos eucarioticos ; procedimiento in vitro para la obtencion de una celula humana que expresa una muteina de un polipeptido blanco humano. celula humana obtenible por dicho procedimiento y uso de dicha celula humana

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP080103620A AR068104A2 (es) 1997-07-23 2008-08-20 Procedimiento in vitro para la produccion de muteinas de polipeptidos eucarioticos ; procedimiento in vitro para la obtencion de una celula humana que expresa una muteina de un polipeptido blanco humano. celula humana obtenible por dicho procedimiento y uso de dicha celula humana

Country Status (17)

Country Link
US (2) US6444441B1 (enExample)
EP (1) EP1000167B2 (enExample)
JP (1) JP2001511341A (enExample)
KR (1) KR100512018B1 (enExample)
CN (2) CN1265152A (enExample)
AR (2) AR013251A1 (enExample)
AT (1) ATE313643T1 (enExample)
AU (1) AU729489B2 (enExample)
BR (1) BR9811531A (enExample)
CA (1) CA2297660C (enExample)
DE (1) DE59813296D1 (enExample)
DK (1) DK1000167T4 (enExample)
ES (1) ES2255177T5 (enExample)
PT (1) PT1000167E (enExample)
TR (1) TR200000172T2 (enExample)
WO (1) WO1999005264A2 (enExample)
ZA (1) ZA986517B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7049253B2 (ja) * 2016-01-06 2022-04-06 ロンザ・リミテッド 産生改善のためのタンパク質分解の阻害

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
DE3907679A1 (de) * 1989-03-09 1990-09-13 Max Planck Gesellschaft Verfahren zur gezielten veraenderung eines gens
JPH0576361A (ja) * 1990-05-10 1993-03-30 Takeda Chem Ind Ltd 組織プラスミノーゲンアクチベータームテイン
AU664976B2 (en) 1990-08-29 1995-12-14 Gene Pharming Europe Bv Homologous recombination in mammalian cells
EP0539573A4 (en) 1991-05-15 1993-12-29 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
JPH07506252A (ja) * 1992-04-24 1995-07-13 エス・アール・アイ・インターナシヨナル 真核細胞内でのイン・ビボ相同配列ターゲッティング
AU5087193A (en) * 1992-08-21 1994-03-15 Regents Of The University Of California, The Composition and method for altering dna sequences by homologous recombination
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (zh) * 1993-12-02 2006-05-24 转移染色体治疗公司 蛋白质的生产和蛋白质的输送
WO1996040271A1 (en) * 1995-06-07 1996-12-19 Yale University Treatment of hemoglobinopathies
US6087129A (en) * 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines

Also Published As

Publication number Publication date
KR100512018B1 (ko) 2005-09-02
DE59813296D1 (de) 2006-01-26
ES2255177T5 (es) 2011-07-12
ZA986517B (en) 2000-01-24
US6444441B1 (en) 2002-09-03
EP1000167B2 (de) 2011-04-20
EP1000167A2 (de) 2000-05-17
WO1999005264A3 (de) 1999-04-22
CN101348789B (zh) 2016-08-17
CA2297660C (en) 2010-04-27
ES2255177T3 (es) 2006-06-16
DK1000167T3 (da) 2006-04-24
CA2297660A1 (en) 1999-02-04
AU9067398A (en) 1999-02-16
CN1265152A (zh) 2000-08-30
JP2001511341A (ja) 2001-08-14
PT1000167E (pt) 2006-05-31
US20020068318A1 (en) 2002-06-06
EP1000167B1 (de) 2005-12-21
KR20010022127A (ko) 2001-03-15
DK1000167T4 (da) 2011-08-08
BR9811531A (pt) 2000-08-22
AR068104A2 (es) 2009-11-04
WO1999005264A2 (de) 1999-02-04
ATE313643T1 (de) 2006-01-15
AU729489B2 (en) 2001-02-01
TR200000172T2 (tr) 2000-12-21
CN101348789A (zh) 2009-01-21
US20020177195A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ES2147720T3 (es) Factor de celulas madre.
ES2169095T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion utilizando celulas modificadas por ingenieria genetica y composiciones farmaceuticas que los contienen.
ES2176174T3 (es) Procedimiento de preparacion de polipeptidos solubles en agua.
NO973848D0 (no) Fremgangsmåte til fremstilling av hemoglobinliknende protein
ATE110108T1 (de) Genetische modifizierung von endothelialen zellen.
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
HN1997000124A (es) Lineas de celulas inmortalizadas para el desarrollo del virus.
ES2300276T3 (es) P40 de interleuquina-12 de mamifero e interleuquina b30. sus combinaciones. anticuerpos. usos en composiciones farmaceuticas.
DK572487D0 (da) Fremgangsmaade til fremstilling af human vaekstfaktor fra endotheliale celler
YU78194A (sh) Dna sastav protein kompleksa i postupak za dobijanje rekombinovanog protein kompleksa
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
DE60031260D1 (de) Vorübergehend-immortalisierte zellen zur verwendung in gentherapie
DE3751632D1 (de) Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen
AU5136900A (en) Process of expressing and isolating recombinant proteins and recombinant proteinproducts from plants, plant derived tissues or cultured plant cells
YU217890A (sh) Postupak za dobijanje genetskih konstrukcija za ekspresiju nervnog faktora rasta u eukariotskim ćelijama
AR013251A1 (es) PROCEDIMIENTO PARA LA PRODUCCION DE MUTEíNAS DE POLIPÉPTIDOS EUCARIoTICOS, PROCEDIMIENTO PARA LA PRODUCCIoN DE UNA CÉLULA HUMANA, QUE NO DE LUGAR A UN INIDIVIDUO COMPLETO, QUE EXPRESA UNA MUTEíNA DE UN POLIPÉPTIDO BLANCO HUMANO, CÉLULA HUMANA OBTENIBLE MEDIANTE DICHO PROCESO Y USO DE DICHA CÉLULA HU
ES8608886A1 (es) Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer.
CN110200842A (zh) 护肤品添加剂

Legal Events

Date Code Title Description
FG Grant, registration